- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
4889
JPX
Week ended 07 Aug 2026
Weekly Investor Report
Renascience Inc. · Healthcare · Medical Devices
Latest close
1,519 JPY
2.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -4.2% below the Trend Line and sits at 19.9% of its 52-week range. The latest completed week returned 2.3%, after a 1.3% four-week move. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal.
Setup score
28
out of 100
Latest Close
1,519 JPY
7 Aug 2026
1W Return
2.3%
latest completed week
4W Return
1.3%
short-term follow-through
12W Return
-20.3%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.3%
Latest completed week; four-week move 1.3%.
Indicator stack
11/78
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -4.2% below the Trend Line and sits at 19.9% of its 52-week range. The latest completed week returned 2.3%, after a 1.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.12
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.3% over four weeks, -20.3% over 12 weeks, and -50.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.35Latest activity-pressure read.
Pressure change266.8%Four-week change in activity pressure.
Leadership-28.33Latest relative-leadership reading.
RS change28.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.1%Distance below the 52-week high.
13-week volatility17.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+51.4%Week of 15 May.
Worst week-18.3%Week of 24 Apr.
Latest week+2.3%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains6
Flat weeks0
Modest losses6
Sharp losses7
Recent vol17.4%13-week weekly-return volatility.
Base vol13.3%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew9.9% / -8.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorJP Healthcare
4-week rank- / 100
Group average1.5%
Trend breadth29.0%
Trend29.0%active weekly trend signals
MD56.0%positive activity pressure
RS13.0%positive relative leadership
Four-week leaders
IndustryJP Medical Devices
4-week rank10 / 21
Group average1.7%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD42.9%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 3 relevant articles.
Renascience Inc. Revenue Breakdown – TSE:4889 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,519 JPY | 2.3% | 1,586 JPY | 1,062 JPY | 0.35 | -28.33 | 873.9K | Off |
| 31 Jul 2026 | 1,485 JPY | -0.9% | 1,586 JPY | 1,055 JPY | 0.26 | -30.66 | 1.1M | Off |
| 24 Jul 2026 | 1,499 JPY | 3.4% | 1,584 JPY | 1,049 JPY | 0.14 | -32.23 | 1.2M | Off |
| 17 Jul 2026 | 1,450 JPY | -3.3% | 1,581 JPY | 1,042 JPY | -0.03 | -35.72 | 3.4M | Off |
| 10 Jul 2026 | 1,499 JPY | -2.0% | 1,591 JPY | 1,036 JPY | -0.21 | -39.46 | 959.0K | Off |
| 3 Jul 2026 | 1,529 JPY | 8.2% | 1,599 JPY | 1,030 JPY | -0.32 | -40.76 | 121.4K | Off |
| 26 Jun 2026 | 1,413 JPY | -12.2% | 1,606 JPY | 1,023 JPY | -0.36 | -45.67 | 1.1M | Off |
| 19 Jun 2026 | 1,610 JPY | 1.4% | 1,632 JPY | 1,018 JPY | -0.43 | -40.49 | 335.7K | Off |
| 12 Jun 2026 | 1,587 JPY | -7.4% | 1,641 JPY | 1,011 JPY | -0.34 | -37.71 | 493.9K | Off |
| 5 Jun 2026 | 1,713 JPY | 24.6% | 1,652 JPY | 1,004 JPY | -0.04 | -34.29 | 958.7K | Off |
| 29 May 2026 | 1,375 JPY | -12.9% | 1,658 JPY | 995.8 JPY | -0.14 | -47.67 | 2.3M | Off |
| 22 May 2026 | 1,579 JPY | -17.1% | 1,676 JPY | 989.8 JPY | -0.25 | -37.64 | 4.4M | Off |
| 15 May 2026 | 1,905 JPY | 51.4% | 1,688 JPY | 982.7 JPY | -0.43 | -23.08 | 4.4M | Off |
| 8 May 2026 | 1,258 JPY | 4.7% | 1,686 JPY | 973.6 JPY | -0.65 | -50.41 | 2.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.